isoxazoles has been researched along with Coronary Artery Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, C; Chai, Y; Cheng, F; Fang, J; Gao, L; Huang, Y; Wang, Q; Zhou, J | 1 |
| Cain, VA; Daly, RN; Ebling, W; Gussak, I; Kopecky, SL; Murphy, J; Pieniaszek, HJ; Simonson, K; Sy, SK; Wilcox, RA; Williams, B; Wright, RS | 1 |
1 trial(s) available for isoxazoles and Coronary Artery Disease
| Article | Year |
|---|---|
The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery disease.
Topics: Aged; Amidines; Angina Pectoris; Bleeding Time; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 2003 |
1 other study(ies) available for isoxazoles and Coronary Artery Disease
| Article | Year |
|---|---|
Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Biological Products; Coronary Artery Disease; Dexamethasone; Drug Repositioning; Humans; Isoxazoles; Systems Biology | 2019 |